688617 logo

APT Medical XSSC:688617 Stock Report

Last Price

CN¥503.68

Market Cap

CN¥33.5b

7D

7.3%

1Y

38.2%

Updated

01 May, 2024

Data

Company Financials +

688617 Stock Overview

APT Medical Inc. engages in the research, development, production, and sale of electrophysiology and interventional medical devices in China.

688617 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth6/6
Past Performance5/6
Financial Health6/6
Dividends2/6

APT Medical Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for APT Medical
Historical stock prices
Current Share PriceCN¥503.68
52 Week HighCN¥507.97
52 Week LowCN¥293.60
Beta-0.51
1 Month Change15.30%
3 Month Change29.09%
1 Year Change38.18%
3 Year Changen/a
5 Year Changen/a
Change since IPO50.77%

Recent News & Updates

Recent updates

Shareholder Returns

688617CN Medical EquipmentCN Market
7D7.3%6.0%4.2%
1Y38.2%-13.9%-13.2%

Return vs Industry: 688617 exceeded the CN Medical Equipment industry which returned -13.9% over the past year.

Return vs Market: 688617 exceeded the CN Market which returned -13.2% over the past year.

Price Volatility

Is 688617's price volatile compared to industry and market?
688617 volatility
688617 Average Weekly Movement5.4%
Medical Equipment Industry Average Movement8.0%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 688617's share price has been volatile over the past 3 months.

Volatility Over Time: 688617's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20022,155Zhenghui Chengwww.aptmed.com

APT Medical Inc. engages in the research, development, production, and sale of electrophysiology and interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, and transseptal needle and sheaths; and interventional cardiology and peripheral intervention products, such as access, diagnostic products, and therapeutic products. It also provides catheters, guidewires, delivery systems, and nitinol products in cardiology, peripheral, neurology, urology, etc. therapeutic applications, as well as accessories; and OEM/ODM services, including project design and development, customization, and volume OEM, etc. The company also exports its products to the United States, Japan, the European Union, Latin America, the Middle East, Russia, the Commonwealth of Independent States, and Africa.

APT Medical Inc. Fundamentals Summary

How do APT Medical's earnings and revenue compare to its market cap?
688617 fundamental statistics
Market capCN¥33.52b
Earnings (TTM)CN¥571.38m
Revenue (TTM)CN¥1.76b

58.7x

P/E Ratio

19.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688617 income statement (TTM)
RevenueCN¥1.76b
Cost of RevenueCN¥510.98m
Gross ProfitCN¥1.24b
Other ExpensesCN¥673.47m
EarningsCN¥571.38m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)8.59
Gross Margin70.90%
Net Profit Margin32.54%
Debt/Equity Ratio0.5%

How did 688617 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

23%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.